Market Place
Sourcing Support
All News #Library
Rare Diseases
Abeona Therapeutics Boosts ZEVASKYN Launch Momentum
09 Mar 2026 //
GLOBENEWSWIRE
Abeona Therapeutics Sets up Zevaskyn Treatment Center in Texas
11 Dec 2025 //
GLOBENEWSWIRE
Abeona Treats First Patient With ZEVASKYN Gene Therapy
08 Dec 2025 //
GLOBENEWSWIRE
Abeona Pharma Secures Permanent J-Code for Zevaskyn
30 Oct 2025 //
GLOBENEWSWIRE
Abeona Pharma`s ABO-503 Gene Therapy For XLRS Chosen For FDA
13 Oct 2025 //
GLOBENEWSWIRE
Abeona, Children`s Hospital Colorado Open ZEVASKYN® Gene Therapy
08 Oct 2025 //
GLOBENEWSWIRE
AscellaHealth & Abeona Launch Novel Gene Therapy for Rare Disease
29 Jul 2025 //
GLOBENEWSWIRE
Abeona Sells Rare Pediatric Disease Voucher for $155 Million
02 Jul 2025 //
GLOBENEWSWIRE
Abeona Ph 3 RDEB Data Published in The Lancet Journal
24 Jun 2025 //
GLOBENEWSWIRE
US FDA approves first cell-based gene therapy for skin disorder
29 Apr 2025 //
PRESS RELEASE
Abeona Announces FDA Acceptance of Pz-cel BLA for EB
12 Nov 2024 //
GLOBENEWSWIRE
Abeona Therapeutics Joins Rare Disease Company Coalition
19 Jul 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.